Post-partum Hemorrhage (PPH) is a leading cause of maternal mortality worldwide, responsible for 70,000 deaths yearly.  

The major challenge in PPH management is late detection and response, particularly in low and middle-income countries. 

A cluster-randomized trial conducted in four countries, Kenya, Nigeria, South Africa, and Tanzania, in partnership with the "WHO Collaborating Centre on Global Women's Health" at the University of Birmingham, United Kingdom, included more than 200000 participants.  

The study showed a 60% reduction in heavy bleeding compared to routine care using an E-MOTIVE package incorporating WHO-recommended treatment bundles for early detection and treatment of PPH.